Axsome Therapeutics to Present Five Abstracts Including New

NEW YORK, April 21, 2023 -- Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today... | April 21, 2023

Related Keywords

China , United States , United Kingdom , New York , Boston , Massachusetts , Japan , Germany , American , British , Mark Jacobson , Stuartj Tepper , Axsome Mo , Darren Opland , Eileen Leary , Zachariah Thomas , Samantha Floam , Hans Van Dongen , Sk Biopharmaceuticals Co Ltd , Affairs At Axsome , Clinical Development At Axsome , Axsome Therapeutics Inc , Geisel School Of Medicine At Dartmouth , Corporate Communications , American Academy Of Neurology , Nasdaq , Airway Pressure , Study Topline Data Press , Drug Administration , Professor At Washington State University , Us Drug Enforcement Agency On , Continuous Positive Airway Pressure , Annual Meeting , Participants During , British Columbia Cognitive Complaints Inventory , Epworth Sleepiness Scale , Washington State University , Cognitive Function , Cognitive Impairment Associated , Excessive Daytime Sleepiness , Obstructive Sleep Apnea , Senior Director , Clinical Development , Preclinical Pharmacology , Potential Mechanisms , Executive Director , Medical Affairs , Solriamfetol Real World Experience Study , Experience During Follow Up , Identifying Areas , Unmet Need Among People , Inadequate Response , Prior Acute Therapies , Risk Factors , Acute Migraine , Geisel School , Cognitive Health , Apnea Participants During , Randomized Placebo Controlled Study , Digit Symbol Substitution Test , Repeatable Battery , Neuropsychological Status , Digit Symbol Substitution , Patient Global Impression , Real World Experience , Enforcement Agency , Full Prescribing Information , Medication Guide , Prescribing Information , Molecular Solubility Enhanced Inclusion Complex , Axsome Therapeutics , Topline Data Press Release , Nc Stock Exchange , News , Information , Press Release , Few , Pril , 023 , Axsome , Iopharmaceutical , Company , Developing , End , Elivering , Novel , Therapies , Or , The , Management , F , Central , Nervous , Ystem Axsm Us05464t1043 ,